Strategic Alliance: InterCure Acquires Stake in Cannasoul to Accelerate Cannabis Pharmaceutical Innovations
NEW YORK & HERZLIYA, Israel – November 3, 2025 – InterCure Ltd., a prominent global cannabis company operating under the Canndoc brand, announced today a significant strategic investment and collaboration with Cannasoul R&D Ltd., a leading pioneer in cannabis research and analytics. The agreements, comprising a Share Purchase Agreement and a Collaboration Agreement, are poised…

